We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

World's First Sensitive and Specific Diagnostic Test to Diagnose Acute Rheumatic Fever

By LabMedica International staff writers
Posted on 30 Sep 2022
Print article
Image: A single, easy-to-deploy test could identify and validate biomarkers for acute rheumatic fever (Photo courtesy of Pexels)
Image: A single, easy-to-deploy test could identify and validate biomarkers for acute rheumatic fever (Photo courtesy of Pexels)

A new project will look to identify and validate biomarkers for acute rheumatic fever (ARF), which initiates a slow but progressive process of heart valve damage dubbed rheumatic heart disease. These biomarkers will serve as a basis for the world’s first sensitive and specific diagnostic test for ARF.

The collaborative network of researchers led by the Cincinnati Children’s Hospital Medical Center (CCHMC, Cincinnati, OH, USA) is dubbed the Acute Rheumatic Fever Diagnosis Collaborative (ARC) Network and comprises experts from six continents who specialize in bacterial pathogenesis, immunology, genetics, system biology, bioinformatics, and epidemiology as well as clinicians living and working in low- and middle-income countries across four continents where RHD remains endemic. These investigators have a strong track record of successful and productive collaboration, with more than 150 co-authored publications on ARF and RHD. ARC expects their discoveries over the next five years to modernize ARF diagnosis and establish a robust platform for future research into the disease. These discoveries will ensure higher quality epidemiological surveillance, inform vaccine safety and trials, and help innovate new strategies for ARF prevention and treatment.

“Despite the high burden of rheumatic heart disease in most low and middle-income countries, rheumatic fever has been incredibly challenging to diagnose,” said Andrea Beaton, MD, pediatric cardiologist at Cincinnati Children’s and lead researcher for this project. “The symptoms of ARF overlap with other common childhood illnesses and lack of a single, easy-to-deploy diagnostic test further hampers diagnosis.”

“The ARC Network brings together an incredible group of global experts who will utilize modern scientific methods to identify a diagnostic test for rheumatic fever,” said Beaton. “Our work has the potential to transform the way we diagnose rheumatic fever globally and to help uncover new targets for prevention and treatment.”

Related Links:
CCHMC 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.